This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationRequest.
Generated Narrative: MedicationRequest medrx0317
identifier: http://www.bmc.nl/portal/prescriptions
/12345689 (use: official, )
status: completed
intent: order
Reference |
Medication alemtuzumab 10 MG/ML [Lemtrada] |
subject: Donald Duck
authoredOn: 2015-01-15
requester: Patrick Pump
Concept |
Chronic lymphoid leukemia, disease (disorder) |
dosageInstruction
sequence: 1
text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk
additionalInstruction: Rapidly increase dose until tolerated, Administer on alternate days
timing: Duration 12weeks , 3 per 1 weeks
route: Intravenous route
method: Inject - dosing instruction imperative (qualifier value)
DoseAndRates
Type Dose[x] Ordered 3 mg (Details: UCUM codemg = 'mg')
dosageInstruction
sequence: 2
text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk
additionalInstruction: Rapidly increase dose until tolerated, Administer on alternate days
timing: Duration 12weeks , 3 per 1 weeks
route: Intravenous route
method: Inject - dosing instruction imperative (qualifier value)
DoseAndRates
Type Dose[x] Ordered 10 mg (Details: UCUM codemg = 'mg')
dosageInstruction
sequence: 3
text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk
additionalInstruction: Rapidly increase dose until tolerated, Administer on alternate days
timing: Duration 12weeks , 3 per 1 weeks
route: Intravenous route
method: Inject - dosing instruction imperative (qualifier value)
DoseAndRates
Type Dose[x] Ordered 30 mg (Details: UCUM codemg = 'mg')
Generated Narrative: Medication #med0303
code: alemtuzumab 10 MG/ML [Lemtrada]
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.